Literature DB >> 12361914

Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control.

Cliffton T H Bong1, Margaret E Bauer, Stanley M Spinola.   

Abstract

Haemophilus ducreyi is the causative agent of the genital ulcer disease chancroid. Chancroid is common in developing countries and facilitates human immunodeficiency virus transmission. In this review, the clinical features, epidemiology, and prospects for disease control are discussed in the context of experimental and natural infection of humans.

Entities:  

Mesh:

Year:  2002        PMID: 12361914     DOI: 10.1016/s1286-4579(02)01639-8

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  27 in total

1.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 2.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

3.  Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR.

Authors:  Maria Labandeira-Rey; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

4.  The Haemophilus ducreyi Fis protein is involved in controlling expression of the lspB-lspA2 operon and other virulence factors.

Authors:  Maria Labandeira-Rey; Dana A Dodd; Chad A Brautigam; Kate R Fortney; Stanley M Spinola; Eric J Hansen
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

5.  Putative vaccine candidates and drug targets identified by reverse vaccinology and subtractive genomics approaches to control Haemophilus ducreyi, the causative agent of chancroid.

Authors:  Alissa de Sarom; Arun Kumar Jaiswal; Sandeep Tiwari; Letícia de Castro Oliveira; Debmalya Barh; Vasco Azevedo; Carlo Jose Oliveira; Siomar de Castro Soares
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

6.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

7.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases.

Authors:  Kaiping Deng; Jason R Mock; Steven Greenberg; Nicolai S C van Oers; Eric J Hansen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.